Alfred Patino, DPM
Podiatrist · Turlock, CANPI 1710042965
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 93.8% of the total across 271 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. Smith+Nephew accounts for 80.7% of it on its own, with 18 other manufacturers making up the rest.
Across 271 payments — averaging $23.47 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Smith+Nephew$5K
- Mimedx Group, Inc.$544
- Osiris Therapeutics Inc.$135
- Amgen$115
- Pacira Therapeutics, Inc.$87
- Resmed Corp$70
- plus $277 from 13 others
What the payments were for
- Travel & lodging$3926%
- Food & beverage$5,96994%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Smith+Nephew | 206 | $5,132 |
| Mimedx Group, Inc. | 27 | $544 |
| Osiris Therapeutics Inc. | 8 | $135 |
| Amgen | 7 | $115 |
| Pacira Therapeutics, Inc. | 5 | $87 |
| Resmed Corp | 2 | $70 |
| Integra Lifesciences Corporation | 4 | $65 |
| Heraeus Medical, LLC. | 1 | $24 |
| Polymedics Innovations Inc. | 1 | $23 |
| Averitas Pharma Inc. | 1 | $19 |
| Kerecis Limited | 1 | $19 |
| Organogenesis Inc. | 1 | $19 |
| Sanofi-aventis U.S. LLC | 1 | $18 |
| Bioventus LLC | 1 | $18 |
| Stryker | 1 | $17 |
| Convatec Inc. | 1 | $16 |
| Johnson & Johnson | 1 | $15 |
| Reprise Biomedical, Inc. | 1 | $14 |
| Merck | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Grafix$707
- PICO$707
- RENASYS TOUCH$707
- Versajet$707
- GRAFIX PL$104
How this compares
$6,361 in reported general payments places this provider in the 85th percentile of 721 podiatrist providers in California.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Ketoconazole | 174 | $4,770 |
| Gabapentin | 126 | $1,337 |
| Pregabalin | 52 | $1,003 |
| Cephalexin | 177 | $741 |
| Celecoxib | 15 | $736 |
| Ammonium Lactate | 31 | $613 |
| Terbinafine Hcl | 30 | $562 |
| Meloxicam | 104 | $522 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 115 | $480 |
| Triamcinolone Acetonide | 34 | $466 |
| Ciclopirox | 16 | $299 |
| Diclofenac Sodium | 24 | $279 |
| Ciprofloxacin Hcl | 33 | $149 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 39 | $127 |
| Amoxicillin | 35 | $102 |
Paid to pharmacies, not to this prescriber.
Other podiatrist in Turlock
- Shannon RushPleasanton$1.9M
- Babak BaravarianSanta Monica$1.1M
- Robert KleimanCalexico$913K
- Bruce LawrenceOceanside$810K
- David ArmstrongLos Angeles$695K
- Philip WrotslavskyPoway$269K
- Travis WestermeyerEncinitas$158K
- Adrienne EstesPomona$129K
- Ronald LiebermanEncinitas$109K
- Matthew DoyleMountain View$92K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.